Results 21 to 30 of about 8,229 (214)
Diagnostic and prognostic value of HE4 in female patients with primary peritoneal carcinoma
Background: HE4 is a useful tumor marker for the diagnosis of ovarian, endometrial, and fallopian tube carcinoma. Aim: The aim of our study was to investigate the value of serum HE4 compared with CA125 in the diagnosis of primary peritoneal carcinoma and
Dong Mi, Yuexiang Zhang
doaj +1 more source
Endobody: Genetically Encodable Nanobody-CPP Chimeras for Degradation of Membrane and Extracellular Proteins. [PDF]
We introduced genetically encodable, receptor‐independent nanobody‐CPP chimeras, termed endobodies, as robust and modular membrane protein degraders. Additionally, proteasome‐targeting domain (PTD)‐tethered endobody demonstrates further enhanced degradation potency.
Zhou C, He H, Xia S, Chen X.
europepmc +2 more sources
Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients? [PDF]
This study assessed the prognostic value of HE4 marker measurements at various stages of first-line chemotherapy for ovarian cancer.The study consisted of 90 ovarian cancer patients, including 48 women undergoing primary surgical treatment and 42 ...
Anita Chudecka-Głaz +3 more
doaj +1 more source
Determination of HE4 in pleural fluid and ratio: considerations and diagnostic performance for malignant pleural effusion. [PDF]
Altres ajuts: This work was funded by the Parc Taulí Research and Innovation Institute Foundation (I3PT), through a grant awarded in the 2023 Taulí Research and Innovation Grants Call, and by the José Luis Castaño-SEQC Foundation through a grant from the
Nuez-Zaragoza E +15 more
europepmc +2 more sources
Objectives: To evaluate whether novel biomarkers of renal injury, serum HE4 and NT-proBNP could predict acute kidney injury (AKI) on chronic kidney disease (CKD) (A on C) and assess the specificity and efficiency of serum creatinine (SCr), HE4 and NT ...
Jinye Song +3 more
doaj +1 more source
Primary chemotherapy treatment response monitoring in advanced epithelial ovarian cancer (EOC) is currently based on CT-imaging and serum CA125 values. Serum HE4 profile during first line chemotherapy has not been previously studied. We evaluated the HE4
Tuulia Vallius +6 more
doaj +1 more source
HE4 in gynecological cancers: report of a European investigators and experts meeting.
The HE4 protein, which belongs to the “ four disulfi de ” acid protein group, has emerged as one of the most promising biomarkers in gynecologic oncology.
PLEBANI, MARIO +2 more
core +1 more source
Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study [PDF]
Introduction: Endometrial Cancer (EC) is a common female malignant disorder. To date, there are no specific tumour markers for EC that may be routinely used in clinical practice for diagnosis. Aim: To evaluate the diagnostic performance of the serum
Rupali Dewan +4 more
doaj +1 more source
HE4: Clinical applications in gynaecological cancer [PDF]
This thesis focuses on the role of biomarker Human Epididymis protein 4 (HE4) in different clinical settings in gynaecological cancer. Part I of this thesis starts with the role of HE4 in epithelial ovarian cancer (EOC).
Stiekema, A.
core +4 more sources
Background We retrospectively analyzed serum level of human epididymis protein 4 (HE4) as a pulmonary inflammatory biomarker in patients with COVID-19 pneumonia in association with disease severity and outcome.
Renáta Sütő +10 more
doaj +1 more source

